THOUSANDS of women with a common form of breast cancer may soon not need any treatment at all, scientists have suggested.
Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as ...
Thomas Jefferson University biostatistician Terry Hyslop designed a trial showing active monitoring to be as effective as ...
Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as 'reassuring' ...
If you’re diagnosed with cancer, asking which stage is likely one of your first questions. Stage 1 is the earliest, most treatable stage of cancer, while stage 4 is the most advanced and difficult to ...
October 27, 2009 — Women with low- to intermediate-grade ductal carcinoma in situ (DCIS) with margins 3 mm or wider had an "acceptably low rate" of ipsilateral breast events 5 years after excision ...
SAN ANTONIO ― Oncologists can now offer postmenopausal women with ductal carcinoma in situ (DCIS) two options for prevention of breast cancer recurrence: anastrozole (Arimidex, AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results